YieldMax MRNA Option Income Strategy ETF
MRNY
3 hedge funds and large institutions have $901K invested in YieldMax MRNA Option Income Strategy ETF in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
2.94% more ownership
Funds ownership: 0% → 2.94% (+2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$432K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.17K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OMC
1
Old Mission Capital
Chicago,
Illinois
| $514K | +$432K | +2,177 | New |
|
|
ZF
2
Zega Financial
Palm Beach Gardens,
Florida
| $384K | +$322K | +1,626 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $3.77K | +$3.17K | +16 | New |
|
MRNY Hedge Fund Activity: Q4 2023 in Review
3 of the 6,865 institutional investors tracked by Wall St. Rank reported a position in YieldMax MRNA Option Income Strategy ETF (MRNY) for Q4 2023, worth a combined $901K.
Buyers outnumbered sellers: 3 funds opened new MRNY positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $432K.
- 3 institutional investors held YieldMax MRNA Option Income Strategy ETF (MRNY) as of Q4 2023, up from 0 in Q3 2023.
- Funds reported $901K of YieldMax MRNA Option Income Strategy ETF stock for Q4 2023.
- 3 funds opened new YieldMax MRNA Option Income Strategy ETF positions in Q4 2023 and 0 closed out, a net change of +3 holders.
- The largest YieldMax MRNA Option Income Strategy ETF buyer in Q4 2023 was Old Mission Capital, an estimated $432K added.
Based on aggregated 13F filings for Q4 2023.